[Glycosylation and L303e/F309S mutations improve intein-mediated splicing of the split coagulation factor VIII]. 2010

Fu-Xiang Zhu, and Ze-Long Liu, and Jing Miao, and Hui-Ge Qu, and Xiao-Yan Chi
Life Science College of Ludong University, Yantai 264025, China. fuxiangmail@163.com

We recently demonstrated that an intein-mediated protein splicing can be used to transfer B-domain-deleted FVIII (BDD-FVIII) gene by a dual-vector. In this study, we observed the effect of a variant heavy chain with six potential glycosylation sites of B domain and L303E/F309S mutations in its A1 domain, which were proven to be beneficial for FVIII secretion, on secretion of spliced BDD-FVIII. By transient co-transfection of cultured 293 cells with intein-fused variant heavy chain (DMN6HCIntN) and light chain (IntCLC) genes, the culture supernatant was analyzed quantitatively by ELISA for secreted spliced BDD-FVIII antigen and by a chromogenic assay for bioactivity. The data showed that the amount of spliced BDD-FVIII protein and coagulation activity in culture supernatant from DMN6HCIntN plus IntCLC co-transfected cells were up to (149 +/- 23) ng x mL(-1) and (1.12 +/- 0.14) u x mL(-1) respectively greater than that of intein-fused wild type heavy (HCIntN) and light chain (IntCLC) co-transfected cells [(99 +/- 14) ng x mL(-1) and (0.77 +/- 0.13) u x mL(-1)] indicating that the variant heavy chain is able to improve the secretion of spliced BDD-FVIII and activity. A cellular mechanism-independent BDD-FVIII splicing was also observed. It provided evidence for ongoing animal experiment using intein-mediated dual-AAV vector technology for delivery of the BDD-FVIII genes.

UI MeSH Term Description Entries
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D005169 Factor VIII Factor VIII of blood coagulation. Antihemophilic factor that is part of the factor VIII/von Willebrand factor complex. Factor VIII is produced in the liver and acts in the intrinsic pathway of blood coagulation. It serves as a cofactor in factor X activation and this action is markedly enhanced by small amounts of thrombin. Coagulation Factor VIII,Factor VIII Clotting Antigen,Factor VIII Coagulant Antigen,Factor VIII Procoagulant Activity,Thromboplastinogen,Blood Coagulation Factor VIII,F VIII-C,Factor 8,Factor 8 C,Factor Eight,Factor VIIIC,Hyate-C,Hyatt-C,F VIII C,Hyate C,HyateC,Hyatt C,HyattC
D006031 Glycosylation The synthetic chemistry reaction or enzymatic reaction of adding carbohydrate or glycosyl groups. GLYCOSYLTRANSFERASES carry out the enzymatic glycosylation reactions. The spontaneous, non-enzymatic attachment of reducing sugars to free amino groups in proteins, lipids, or nucleic acids is called GLYCATION (see MAILLARD REACTION). Protein Glycosylation,Glycosylation, Protein
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014162 Transfection The uptake of naked or purified DNA by CELLS, usually meaning the process as it occurs in eukaryotic cells. It is analogous to bacterial transformation (TRANSFORMATION, BACTERIAL) and both are routinely employed in GENE TRANSFER TECHNIQUES. Transfections
D047668 Inteins The internal fragments of precursor proteins (INternal proTEINS) that are autocatalytically removed by PROTEIN SPLICING. The flanking fragments (EXTEINS) are ligated forming mature proteins. The nucleic acid sequences coding for inteins are considered to be MOBILE GENETIC ELEMENTS. Inteins are composed of self-splicing domains and an endonuclease domain which plays a role in the spread of the intein's genomic sequence. Mini-inteins are composed of the self-splicing domains only. Introns, Protein,Protein Introns,Intervening Protein Sequence,Intein,Intervening Protein Sequences,Intron, Protein,Protein Intron,Protein Sequence, Intervening,Protein Sequences, Intervening,Sequence, Intervening Protein,Sequences, Intervening Protein
D057809 HEK293 Cells A cell line generated from human embryonic kidney cells that were transformed with human adenovirus type 5. 293T Cells,HEK 293 Cell Line,HEK 293 Cells,Human Embryonic Kidney Cell Line 293,Human Kidney Cell Line 293,293 Cell, HEK,293 Cells, HEK,293T Cell,Cell, 293T,Cell, HEK 293,Cell, HEK293,Cells, 293T,Cells, HEK 293,Cells, HEK293,HEK 293 Cell,HEK293 Cell
D019154 Protein Splicing The excision of in-frame internal protein sequences (INTEINS) of a precursor protein, coupled with ligation of the flanking sequences (EXTEINS). Protein splicing is an autocatalytic reaction and results in the production of two proteins from a single primary translation product: the intein and the mature protein. Protein Splicings,Splicing, Protein,Splicings, Protein
D020040 Trans-Splicing The joining of RNA from two different genes. One type of trans-splicing is the "spliced leader" type (primarily found in protozoans such as trypanosomes and in lower invertebrates such as nematodes) which results in the addition of a capped, noncoding, spliced leader sequence to the 5' end of mRNAs. Another type of trans-splicing is the "discontinuous group II introns" type (found in plant/algal chloroplasts and plant mitochondria) which results in the joining of two independently transcribed coding sequences. Both are mechanistically similar to conventional nuclear pre-mRNA cis-splicing. Mammalian cells are also capable of trans-splicing. RNA Trans-Splicing,Trans RNA Splicing,Trans Splicing,RNA Splicing, Trans,RNA Trans Splicing,Splicing, Trans,Trans-Splicings, RNA

Related Publications

Fu-Xiang Zhu, and Ze-Long Liu, and Jing Miao, and Hui-Ge Qu, and Xiao-Yan Chi
January 1999, Biopolymers,
Fu-Xiang Zhu, and Ze-Long Liu, and Jing Miao, and Hui-Ge Qu, and Xiao-Yan Chi
March 2018, The Biochemical journal,
Fu-Xiang Zhu, and Ze-Long Liu, and Jing Miao, and Hui-Ge Qu, and Xiao-Yan Chi
January 2017, Methods in molecular biology (Clifton, N.J.),
Fu-Xiang Zhu, and Ze-Long Liu, and Jing Miao, and Hui-Ge Qu, and Xiao-Yan Chi
January 2016, Revista brasileira de hematologia e hemoterapia,
Fu-Xiang Zhu, and Ze-Long Liu, and Jing Miao, and Hui-Ge Qu, and Xiao-Yan Chi
March 2006, Angewandte Chemie (International ed. in English),
Fu-Xiang Zhu, and Ze-Long Liu, and Jing Miao, and Hui-Ge Qu, and Xiao-Yan Chi
August 2017, Scientific reports,
Fu-Xiang Zhu, and Ze-Long Liu, and Jing Miao, and Hui-Ge Qu, and Xiao-Yan Chi
April 2007, Biochemical and biophysical research communications,
Fu-Xiang Zhu, and Ze-Long Liu, and Jing Miao, and Hui-Ge Qu, and Xiao-Yan Chi
January 2015, PloS one,
Fu-Xiang Zhu, and Ze-Long Liu, and Jing Miao, and Hui-Ge Qu, and Xiao-Yan Chi
February 2016, Journal of the American Chemical Society,
Fu-Xiang Zhu, and Ze-Long Liu, and Jing Miao, and Hui-Ge Qu, and Xiao-Yan Chi
August 2004, Biochemistry,
Copied contents to your clipboard!